Issue link:

Contents of this Issue


Page 16 of 31

Information about devices that may be useful in research and development or manufacturing. Content is provided by companies, with no preference intended. Inhalation OctOber 2018 15 Issue Focus This section of Inhalation provides information that may be useful in research and development or manufacturing. Content is provided by the companies listed. No product endorsement or preference is intended. devices New equipment for testing albuterol inhalation aerosols Albuterol is a popular generic used globally for the treatment of asthma and COPD. The newly proposed USP monograph for Albuterol Inhalation Aerosols, released in Jan- uary 2018, specifies a non-standard sampling apparatus for DDU test- ing, and an alternative to the stan- dard USP induction port for APSD measurement, using an Andersen Cascade Impactor. Copley Scien- tific provides solutions to directly meet these requirements along with associated accessories. Copley Scientific UK: +44 1159 616229 Automated inhaler testing solutions Astech Projects specializes in the supply of automated inhaler testing equipment for all device types including DPI, MDI and BAI. Astech's award-winning X-Products ® range, which includes Xelair ® , Xelize ® and Xelox ® , provides robust, durable and consistent testing for Dose Content Uniformity (DCU) and Particle Size Determination (PSD), including Andersen and NGI Impactors. Custom automation solutions are also available for waste firing, physical device testing, emitted dose weight, vision and inspection. Astech offers a comprehensive maintenance and support service called REACTS ® , providing peace of mind for the lifetime of the system. Astech Projects Ltd UK: +44 1928 571797 Spray pattern and plume geometry as screening tools Spray characterization based on the effects of device design, formulation and patient usage factors can have a significant impact on successful OINDP development and quality control. Quantitative and qualitative spray data derived from testing of critical device design variables (orifice length, orifice diameter and chamber depth) produces essential information for achieving BA/BE goals. Proveris aids in evaluating these variables using spray pattern and plume geometry as sensitive screening tools. Studies are performed using a Quality by Design (QbD) approach recommended by the FDA and come with detailed reports summarizing project objectives and results. Proveris Scientific Corporation US: +1 508 460-8822

Articles in this issue

Links on this page

view archives of Inhalation - INH1018